{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:50:26Z","timestamp":1774864226398,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":182,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1111\/jth.15449","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T11:56:01Z","timestamp":1626177361000},"page":"2495-2503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Post\u2010thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long\u2010term cross\u2010sectional follow\u2010up of RE\u2010COVER study patients"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1035-5521","authenticated-orcid":false,"given":"Hilde Skuterud","family":"Wik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-8916","authenticated-orcid":false,"given":"Susan R.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-3615","authenticated-orcid":false,"given":"David","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-6165","authenticated-orcid":false,"given":"Waleed","family":"Ghanima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-9043","authenticated-orcid":false,"given":"Sam","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-8099","authenticated-orcid":false,"given":"Per Morten","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1111\/jth.15449_bb0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jth.14728","article-title":"Long\u2010term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: the CACTUS\u2010PTS study","volume":"18","author":"Galanaud","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1111\/jth.15449_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1160\/TH17-08-0598","article-title":"Predictors of post\u2010thrombotic ulcer after acute DVT: the RIETE registry","volume":"118","author":"Galanaud","year":"2018","journal-title":"Thromb Haemost"},{"issue":"9810","key":"10.1111\/jth.15449_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long\u2010term outcome after additional catheter\u2010directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1111\/jth.15449_bb0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post\u2010thrombotic syndrome","volume":"2016","author":"Kahn","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1111\/jth.15449_bb0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1538-7836.2005.01333.x","article-title":"Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome","volume":"3","author":"van Dongen","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1111\/jth.15449_bb0035","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1538-7836.2012.04872.x","article-title":"Risk of post\u2010thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study","volume":"10","author":"Chitsike","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"24","key":"10.1111\/jth.15449_bb0040","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1111\/jth.15449_bb0045","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1111\/jth.15449_bb0050","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Buller","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1111\/jth.15449_bb0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1111\/jth.15449_bb0060","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1111\/jth.15449_bb0065","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Buller","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1111\/jth.15449_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1111\/jth.15449_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor's Choice \u2010 European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1111\/jth.15449_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11239-015-1314-3","article-title":"Pharmacology of anticoagulants used in the treatment of venous thromboembolism","volume":"41","author":"Nutescu","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1111\/jth.15449_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0609.2011.01733.x","article-title":"Healthcare burden associated with the post\u2010thrombotic syndrome and potential impact of the new oral anticoagulants","volume":"88","author":"Prandoni","year":"2012","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1111\/jth.15449_bb0090","first-page":"733","article-title":"Post\u2010thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep\u2010vein thrombosis. A post\u2010hoc analysis","volume":"116","author":"Cheung","year":"2016","journal-title":"Thromb haemost"},{"key":"10.1111\/jth.15449_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2017.05.029","article-title":"Rivaroxaban versus warfarin in the prevention of post\u2010thrombotic syndrome","volume":"157","author":"Jeraj","year":"2017","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15449_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.thromres.2018.01.013","article-title":"Rivaroxaban versus warfarin for the prevention of post\u2010thrombotic syndrome","volume":"163","author":"Utne","year":"2018","journal-title":"Thromb Res"},{"issue":"4","key":"10.1111\/jth.15449_bb0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1076029618758955","article-title":"Postthrombotic syndrome in patients treated with rivaroxaban or warfarin for venous thromboembolism","volume":"24","author":"Coleman","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"10.1111\/jth.15449_bb0110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.amjmed.2018.01.041","article-title":"Rivaroxaban versus warfarin and risk of post\u2010thrombotic syndrome among patients with venous thromboembolism","volume":"131","author":"S\u00f8gaard","year":"2018","journal-title":"Am J Med"},{"issue":"6","key":"10.1111\/jth.15449_bb0115","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.surg.2019.05.030","article-title":"Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin","volume":"166","author":"de Athayde Soares","year":"2019","journal-title":"Surgery"},{"key":"10.1111\/jth.15449_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2019.106608","article-title":"Low prevalence of Post\u2010thrombotic syndrome in patients treated with rivaroxaban","volume":"124","author":"Ferreira","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"10.1111\/jth.15449_bb0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.thromres.2020.09.014","article-title":"Risk of post\u2010thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin\u2010K antagonists: a systematic review and meta\u2010analysis","volume":"196","author":"Li","year":"2020","journal-title":"Thromb Res"},{"issue":"3","key":"10.1111\/jth.15449_bb0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11739-019-02215-z","article-title":"The risk of post\u2010thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants","volume":"15","author":"Prandoni","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1111\/jth.15449_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvsv.2021.04.016","article-title":"Efficacy of rivaroxaban in prevention of post\u2010thrombotic syndrome: a systematic review and meta\u2010analysis","author":"Karathanos","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"2","key":"10.1111\/jth.15449_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1160\/th15-04-0318","article-title":"Development and validation of a tool for patient reporting of symptoms and signs of the post\u2010thrombotic syndrome","volume":"115","author":"Utne","year":"2016","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1111\/jth.15449_bb0145","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2009.03339.x","article-title":"Measurement properties of the Villalta scale to define and classify the severity of the post\u2010thrombotic syndrome","volume":"7","author":"Kahn","year":"2009","journal-title":"J Thromb haemost"},{"key":"10.1111\/jth.15449_bb0150","first-page":"158a","article-title":"Assessment of validity and reproducibility of a clinical scale for the post thrombotic syndrome","volume":"24","author":"Villalta","year":"1994","journal-title":"Haemostasis"},{"issue":"5","key":"10.1111\/jth.15449_bb0155","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1538-7836.2009.03294.x","article-title":"Definition of post\u2010thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization","volume":"7","author":"Kahn","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15449_bb0160","unstructured":"EuroQol. https:\/\/euroqol.org. Accessed April 4 2021."},{"issue":"2","key":"10.1111\/jth.15449_bb0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mva.2003.152","article-title":"Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient\u2010reported measure of symptoms and quality of life","volume":"37","author":"Lamping","year":"2003","journal-title":"J Vasc Surg"},{"issue":"10","key":"10.1111\/jth.15449_bb0170","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jclinepi.2005.10.016","article-title":"VEINES\u2010QOL\/Sym questionnaire was a reliable and valid disease\u2010specific quality of life measure for deep venous thrombosis","volume":"59","author":"Kahn","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1111\/jth.15449_bb0175","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s11136-014-0704-x","article-title":"The VEINES\u2010QOL\/Sym questionnaire is a reliable and valid disease\u2010specific quality of life measure for deep vein thrombosis in elderly patients","volume":"23","author":"M\u00e9an","year":"2014","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1111\/jth.15449_bb0180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-6712.2008.00618.x","article-title":"Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES\u2010QOL\/Sym, a disease\u2010specific questionnaire","volume":"23","author":"Enden","year":"2009","journal-title":"Scand J Caring Sci"},{"key":"10.1111\/jth.15449_bb0185","series-title":"SF\u201036 Physical and Mental Health Summary Scales: A User's Manual","author":"Ware","year":"1994"},{"key":"10.1111\/jth.15449_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2020.04.036","article-title":"Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD\u2010VTE","volume":"191","author":"Bounameaux","year":"2020","journal-title":"Thromb Res"},{"issue":"1","key":"10.1111\/jth.15449_bb0195","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1186\/s40064-016-2949-z","article-title":"Health\u2010related quality of life after deep vein thrombosis","volume":"5","author":"Utne","year":"2016","journal-title":"SpringerPlus"},{"issue":"7","key":"10.1111\/jth.15449_bb0200","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1538-7836.2008.03002.x","article-title":"Determinants of health\u2010related quality of life during the 2 years following deep vein thrombosis","volume":"6","author":"Kahn","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1111\/jth.15449_bb0205","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1538-7836.2012.04690.x","article-title":"Prevalence and predictors for post\u2010thrombotic syndrome 3 to 16 years after pregnancy\u2010related venous thrombosis: a population\u2010based, cross\u2010sectional, case\u2010control study","volume":"10","author":"Wik","year":"2012","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15449","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15449","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:50:47Z","timestamp":1774860647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362202150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S153878362202150X"],"URL":"https:\/\/doi.org\/10.1111\/jth.15449","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post\u2010thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long\u2010term cross\u2010sectional follow\u2010up of RE\u2010COVER study patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}